Life Sciences

Natera Stock Expands into Cancer Blood Testing

To say it’s been a tough year for retail investors would be an understatement. That’s especially true for technology stocks, with the Nasdaq down 35% for the year compared to about a 20% drop for the S&P 500. Interestingly, biotech stocks haven’t done as bad, based on the broad NASDAQ Biotechnology Index (NBI), which currently […]

Exact Sciences Stock Expands into Liquid Biopsy Market

Did you know that as early as the 1930s scientists were using wastewater – specifically, human excreta – to track disease outbreaks like polio well before the Rona came to town? Here’s another interesting scientific scoop on poop: One of the best treatments for people suffering from a serious bacterial gut infection is a fecal […]

Guardant Stock Plummets on Study Results

You know your consumer product is scaling when Katie Couric gives it a shout out. It’s even better when the product relates to something Ms. Couric feels very strongly about – colon cancer. Her husband died of colon cancer at the age of 42 in 1998. Several years later, Ms. Couric had a live colonoscopy […]

Is Freenome a Leading Cancer Blood-Testing Company?

The meltdown of the cryptocurrency exchange FTX is just the latest reminder that it can take time – and billions of dollars lost – to catch fraud, even when there are more red flags waving than in a Russian parade. For starters, any company flying its flag from the Bahamas should at least raise an […]

CareDx Stock is Pure Play on Organ Transplant Diagnostics

You know those pop TV shows that ask burning questions like, “Where are they now?” Usually, the episode will pick some child star who flamed out early, spending the better part of their youth burning through rerun royalties with drugs and alcohol. Today, little Johnny Boy is three years sober and doing a podcast interviewing […]

Oramed Pharmaceuticals and the Promise of Oral Insulin

You know how to tell someone is an Apple user? They’ll tell you. That old joke refers to the inability for some people to keep facts hidden as they betray themselves repeatedly. We’ve been dealing with stock promoters and cheerleaders for decades now, and inevitably they’ll find their way to Nanalyze and quickly betray themselves. […]

908 Devices Stock: Pure Play in Mini Mass Spectrometers

Butterfly Network (BFLY) is a company that we’ve liked ever since first writing about its handheld ultrasound device more than six years ago while reviewing some of the top AI startups in healthcare. While the technology is complicated, the concept is pretty simple: Shrink the capabilities of an ultrasound machine down to the size of […]

Illumina Stock Falls on GRAIL Acquisition Fail

Unless you can watch your stock holding decline by 50% without becoming panic-stricken, you should not be in the stock market,” says Warren Buffet. That advice couldn’t be more applicable today as the bear market continues to hit new lows. To feel comfortable with your portfolio in the red, you need to invest in quality […]

Cold Chain Logistics Stocks: BioLife vs Cryoport

A few months ago, we held a cage match between two of the leading gene-editing stocks. Basically, it ended in a draw, leaving us with a mini portfolio in this potentially lucrative but extremely volatile life sciences/nanotech market. Generally risk-averse investors, we’re always looking for ways to get exposure to an emerging technology theme like […]

Is Fulgent Genetics Stock More Than a One-Hit Wonder?

Our MBAs at Nanalyze are constantly tweaking our disruptive tech investing methodology, adapting our metrics as we play through one of the weirdest post-bull runs in Wall Street history – and that’s saying a lot. Gone are the days of growth at all costs, but that’s been the mantra of the tech sector for a […]